Precision Peptide orders 20,000 Thymosin Alpha-1 patches for launch

The Precision Peptide Company says it has ordered 20,000 Thymosin Alpha-1 patches for a commercial launch, with an initial U.S. production run moving its second transdermal peptide product toward direct-to-consumer and wholesale availability.